Abstract:Background/Synopsis Multifactorial chylomicronemia syndrome (MCS), also known as type V hyperlipoproteinemia, is a rare polygenic disorder characterized by severe hypertriglyceridemia. It is triggered by uncontrolled diabetes mellitus (DM), obesity, metabolic syndrome, and certain medications. It is not known whether hypertriglyceridemia associated with MCS accelerates atherosclerotic cardiovascular disease (ASCVD). Objective/Purpose To speculate the relationship between ASCVD in a patient with hypertriglyceridemia caused by MCS, uncontrolled DM, and polymorphic APOA5, APOE2/4, LMF1 and LP(a) intron mutations. Methods We present a 60-year-old male with PMH of severe hypertriglyceridemia (highest 6000mg/dL) with acute pancreatitis at age 40, CAD s/p CABG at age 50, PAD s/p bypass at age 57, HTN, mixed hyperlipidemia, uncontrolled DM, and family history of premature ASCVD. He was subsequently followed at the advanced lipid clinic where his medications included rosuvastatin, ezetimibe, evolocumab, fenofibrate, and icosapent ethyl. He underwent advanced genetic testing with GBinsight. Results GBinsight identified various polymorphic genes causing hypertriglyceridemia as follows: APOA5 - c.*158C>T(rs2266788) - This variant is found in ∼10% of the global population and has been associated with hypertriglyceridemia by multiple genome-wide association studies. APOA5 - c.457G>A(p.Val153Met)(rs3135507) - This variant is found in ∼5-10% of the global population and has been associated with modest hypertriglyceridemia and lower HDL-C in the UKBiobank cohort. APOE2 - This allele has been associated with a reduction of the major lipolytic enzyme, lipoprotein lipase (LPL) activity, causing modest hypertriglyceridemia. LMF1 - p.Arg354Trp(rs143076454) - This variant is found in ∼2% of the global population, and has been associated with a reduction of LPL activity causing modest hypertriglyceridemia. GBinsight identified various pathogenic genes causing elevated Lp(a) as follows: LPA - Heterozygous for intron c.3947+467T>C(rs10455872) - This variant serves a genetic proxy for short isoforms and is strongly associated with increased Lp(a), total and LDL-cholesterol levels, and increased ASCVD risk. APOE4 - This allele is associated with increased Lp(a) levels. Conclusions We speculate that the combination of these polymorphisms works together to increase risk of severe hypertriglyceridemia, also known as MCS. Several smaller studies have suggested MCS is caused by either of the two major mechanisms: (1) some combination of minor genetic polymorphisms, or (2) presence of a single genetic mutation in one of the five genes regulating triglyceride metabolism including LPL, APOC2, APOA5, GPHIBP1, and LMF1. We postulate acceleration of ASCVD in our patient with MCS was multifactorial, including deposition of atherogenic triglyceride rich lipoproteins within blood vessels, in addition to the independent risk factor of elevated Lp(a). Furthermore, he had poorly controlled DM and insulin resistance owing to the increased circulating triglycerides, which further increased endothelial lining damage and accelerated ASCVD.

Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass

A Heterozygous LMF1 Gene Mutation (c.1523C>T), Combined With an LPL Gene Mutation (c.590G>A), Aggravates the Clinical Symptoms in Hypertriglyceridemia

Compound but Non-Linked Heterozygous P.w14x and P.l279 V LPL Gene Mutations in a Chinese Patient with Long-Term Severe Hypertriglyceridemia and Recurrent Acute Pancreatitis.

Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis.

Identification of a Novel LPL Nonsense Variant and Further Insights into the Complex Etiology and Expression of Hypertriglyceridemia-Induced Acute Pancreatitis

Identification of a Novel and Heterozygous LMF1 Nonsense Mutation in an Acute Pancreatitis Patient with Severe Hypertriglyceridemia, Severe Obesity and Heavy Smoking

Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia

A Novel Lipoprotein Lipase Gene Missense Mutation in Chinese Patients with Severe Hypertriglyceridemia and Pancreatitis

Significant but partial lipoprotein lipase functional loss caused by a novel occurrence of rare LPL biallelic variants

Identification and Functional Characterization of a Novel Heterozygous Missense Variant in the LPL Associated with Recurrent Hypertriglyceridemia‐induced Acute Pancreatitis in Pregnancy

Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.

Digenic Inheritance and Gene-Environment Interaction in a Patient With Hypertriglyceridemia and Acute Pancreatitis

Identification and Characterization of Two Novel Compounds: Heterozygous Variants of Lipoprotein Lipase in Two Pedigrees With Type I Hyperlipoproteinemia

A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia

A Novel APOC2 Gene Mutation Identified in a Chinese Patient with Severe Hypertriglyceridemia and Recurrent Pancreatitis

Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis

Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia – Case Report and Literature Review

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.

Accelerated Atherosclerosis in a Patient With Multifactorial Chylomicronemia Syndrome (MCS), Elevated Lp(a), APOE2/4 Genotype and Diabetes Mellitus.

Sequencing of Lipoprotein Lipase Gene in 11 Cases of Chinese Patients with Severe Endogenous Hypertriglyceridemia.